# Ilant Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ilant-health

- Industry: Healthcare IT
- Headquarters: Albany, US
- Website: www.ilanthealth.com
- Total disclosed funding: $40M
- Latest round: Series B (Jun 17, 2026)
- Investors on record: 10

## About

Based in New York, US, and founded in 2022 by CEO Elina Onitskansky, Ilant Health, Inc., a.k.a. Ilant Health operates as a healthcare company that focuses on providing access to obesity treatment while reducing the total cost of care for employers and payers. In June 2026, Ilant Health, Inc. raised USD 15 million in series A funding led by Cornucopian Capital, with participation from Alpha Analytical, Inc., Celtic House Asia Partners, Life Extension Ventures, Evidenced, naturalX Health Ventures, Operator Collective, PeakBridge, and SEMCAP.
The company utilizes its proprietary analytics engine, Ilant Rapid Returns (IRR), to match individuals in need of treatment related to obesity. Ilant Health provides a wide range of treatment options, such as integrative behavioral therapy, medications, and bariatric surgery, to its patients. In addition, the firm offers evidence-based solutions, such as bariatric surgery, medication, intense behavioral therapy, and more, through a technology-enabled and analytics-driven obesity medicine practice.

The company will use the June 2026 funding to improve health outcomes while helping employers and payers manage healthcare costs.

## Funding rounds

- Series B, Jun 17, 2026, $15M — AlphaLab, PeakBridge, SEMCAP, Operator Collective, Celtic House Asia Partners, Cornucopian Capital, Life Extension Ventures, Evidenced, naturalX Health Ventures
- Series A, Mar 27, 2026, $22M — PeakBridge, SEMCAP, Operator Collective, Celtic House Asia Partners, Cornucopian Capital, Life Extension Ventures, Evidenced, Alpha Analytical, Inc., naturalX Health Ventures
- Seed, Apr 17, 2024, $2.5M — Celtic House Asia Partners, Cornucopian Capital, Life Extension Ventures

## Investors

- Celtic House Asia Partners (https://capitalatlas.ai/funds/celtic-house-asia-partners) — Seed, Series A, Series B
- Cornucopian Capital (https://capitalatlas.ai/funds/cornucopian-capital) — Seed, Series A, Series B
- Life Extension Ventures (https://capitalatlas.ai/funds/life-extension-ventures) — Seed, Series A, Series B
- PeakBridge (https://capitalatlas.ai/funds/peakbridge) — Series A, Series B
- SEMCAP (https://capitalatlas.ai/funds/semcap) — Series A, Series B
- Operator Collective (https://capitalatlas.ai/funds/operator-collective) — Series A, Series B
- Evidenced (https://capitalatlas.ai/funds/evidenced) — Series A, Series B
- Alpha Analytical, Inc. — Series A
- naturalX Health Ventures (https://capitalatlas.ai/funds/naturalx-health-ventures) — Series A, Series B
- AlphaLab — Series B